Dr. Kartik Konduri, MD
Claim this profileTexas Oncology-Baylor Charles A. Sammons Cancer Center
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
11 reported clinical trials
21 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
Stage III
EGFR positive
2Lung Cancer
Stage IV
Stage III
NRG1 positive
Affiliated Hospitals
Clinical Trials Kartik Konduri, MD is currently running
TTFields + Pembrolizumab
for Lung Cancer
This is a multicenter, randomized, open-label study of Tumor Treating Fields (TTFields) at 150 kHz to the thorax using the NovoTTF-200T System with IV pembrolizumab in subjects previously untreated for advanced or metastatic, PD-L1 positive non-small cell lung cancer (NSCLC). The primary objective is to evaluate the progression-free survival (PFS) by RECIST 1.1 in subjects with TPS ≥1 percent, 1L metastatic/current advanced NSCLC treated with TTFields concomitant with pembrolizumab compared to those treated with pembrolizumab alone. The device is an experimental, portable, battery operated device for chronic administration of alternating electric fields (termed TTFields) to the region of the malignant tumor, by means of surface, insulated electrode arrays.
Recruiting1 award Phase 28 criteria
LP-300 + Chemotherapy
for Lung Adenocarcinoma EGFR
This trial tests a new drug, LP-300, combined with two existing chemotherapy drugs in never smokers with a specific type of lung cancer who did not respond to previous treatments. The goal is to see if this combination improves survival by making the chemotherapy more effective.
Recruiting3 awards Phase 24 criteria
More about Kartik Konduri, MD
Clinical Trial Related3 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Kartik Konduri, MD has experience with
- Pemetrexed
- Carboplatin
- Placebo
- Pembrolizumab
- NovoTTF-200T
- Seribantumab
Breakdown of trials Kartik Konduri, MD has run
Non-Small Cell Lung Cancer
Lung Cancer
Head and Neck Cancers
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kartik Konduri, MD specialize in?
Kartik Konduri, MD focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Kartik Konduri, MD currently recruiting for clinical trials?
Yes, Kartik Konduri, MD is currently recruiting for 3 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Kartik Konduri, MD has studied deeply?
Yes, Kartik Konduri, MD has studied treatments such as Pemetrexed, Carboplatin, Placebo.
What is the best way to schedule an appointment with Kartik Konduri, MD?
Apply for one of the trials that Kartik Konduri, MD is conducting.
What is the office address of Kartik Konduri, MD?
The office of Kartik Konduri, MD is located at: Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas 75246 United States. This is the address for their practice at the Texas Oncology-Baylor Charles A. Sammons Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.